Monitoring antibody binding to T cells in a pembrolizumab‐treated patient with lung adenocarcinoma on hemodialysis

Recent clinical trials have demonstrated that anti‐PD‐1 blocking antibodies showed remarkable clinical efficacy in a subset of non‐small cell lung cancer (NSCLC) patients. Clinical trials usually exclude patients with renal dysfunction who are receiving hemodialysis (HD). Therefore, it is unclear wh...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Thorac Cancer
Main Authors: Osa, Akio, Uenami, Takeshi, Naito, Yujiro, Hirata, Haruhiko, Koyama, Shohei, Takimoto, Takayuki, Shiroyama, Takayuki, Futami, Shinji, Nakatsubo, Saeko, Sawa, Nobuhiko, Yano, Yukihiro, Nagatomo, Izumi, Takeda, Yoshito, Mori, Masahide, Kida, Hiroshi, Kumanogoh, Atsushi
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons Australia, Ltd 2019
Assuntos:
Case Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6825915/
https://ncbi.nlm.nih.gov/pubmed/31520515
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13197
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados